Pfizer secures China nod for obesity drug as generics loom

China has approved a new obesity treatment from Pfizer Inc., heightening competition in a market poised to become even more ...

China approves Pfizer GLP-1 drug for weight loss

By Andrew Silver SHANGHAI, March 6 (Reuters) - China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight ...
Texarkana Gazette

Pfizer to make generic Viagra pill available beginning Monday

TRENTON, N.J.-The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales ...
Fierce Biotech

Pfizer adds to Seagen scrap heap with another early cancer candidate cull

About a month after Pfizer CEO Albert Bourla, Ph.D., told investors that the Big Pharma’s pipeline pruning was mostly done, ...
Fierce Pharma

Pfizer eyes earlier Talzenna use after phase 3 prostate cancer win

Pfizer is eyeing an earlier use of its PARP inhibitor Talzenna after a positive phase 3 trial in metastatic hormone-sensitive prostate cancer (mHSPC). | After an FDA snub in a broader metastatic ...

Pfizer posts late-stage trial win for Talzenna plus Xtandi in new prostate cancer indication

Pfizer (PFE) stock is in focus as Xtandi, marketed with Astellas (ALPMF), and cancer drug Talzenna succeed in a Phase 3 trial for prostate cancer. Read more here.